UPC APP 68655/2024

—

Case details: Status
—
Action
Procedural application
Category
Withdrawal Applications
Parties: Claimants
DexCom, Inc.
Reps: Anne-Charlotte le Bihan (Bird & Bird LLP); Laurent Labatte (Bird & Bird LLP); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)
Respondents
Abbott Laboratories
Abbott Diabetes Care Inc.
Abbott GmbH
Abbott Diagnostics GmbH
Abbott Logistics B.V.
Abbott (S.A./N.V.)
Abbott s.r.l.
Abbott B.V.
Abbott Scandinavia Aktiebolag
Abbott France (S.A.S.)
Division: Court of Appeal
Judges: —
Language: —
First decided: Jan 24, 2025

Decisions

2025-01-24
WithdrawnApplication Rop 265
The Court of Appeal allowed DexCom's withdrawal of its infringement action and Abbott's withdrawal of the counterclaims for revocation, declared the proceedings closed, and ordered reimbursement of 60% of DexCom's court fees; as a result the first instance decision revoking DexCom's patent became ineffective.
Legal issues:Withdrawal of infringement action on appeal (R. 265 RoP)Effect of withdrawal on prior revocation decisionReimbursement of court fees (R. 370.9 RoP)

Documents